Background. Background. Background. Curriculum Design and Editorial Process. Creating a PD Curriculum. ASDIN HVA Core Curriculum
|
|
- Brent Franklin
- 5 years ago
- Views:
Transcription
1 Background Creating a PD Curriculum Steven Wu, MD Director of Interventional Nephrology Massachusetts General Hospital Harvard Medical School The scope of our current practice as a new subspecialty within nephrology. Hemidlaysis AV access management Peritoneal dialysis catheter placement Kidney ultrasound and biopsy Renal artery stenosis and peripheral artery disease 2 ASDIN HVA Core Curriculum Background ASDIN Core Curriculum for Interventional Nephrology (HVA) Author: Dr. Gerald Beathard Well-written and well-perceived Available for purchasing at the ASDIN website Served as the core curriculum of hemodialysis AV access management within Interventional Nephrology 4 Background Curriculum Design and Editorial Process 5 Need of a similar core curriculum for peritoneal dialysis catheter procedures: Peritoneal dialysis catheter placement procedures represent the second largest practice by interventional nephrologists Multiple approaches A similar curriculum for peritoneal dialysis catheter procedures to meet the needs of ASDIN members. ASDIN Education Committee agendas Education Committee - Curriculum Subcommittee Chair: Steven Wu, MD Members: Loay Salman, MD Bharat Sachdeva, MD Lisa Nanovic, MD Anil Agarwal, MD Ivan Maya, MD 1
2 Table of the Contents Table of the Contents 7 Chapter 1. Introduction Arif Asif M.D. and Loay Salman M.D. Chapter 2. Peritoneal Dialysis Catheters Designs and Overview of Placement Techniques Stephen Ash M.D., Anil Agarwal, M.D. Chapter 3. Definition of Peritoneal Dialysis Catheter Complications and Proper Function Stephen Ash M.D., Anil Agarwal, M.D. 8 Chapter 4. Surgical Placement of Peritoneal Dialysis Catheters (Dissective Placement) Amer Rajab MD, PhD, Mitchell Henry, MD; Chapter 5. A Technique of Laparoscopic Tenckhoff catheter: Same Day Peritoneal Dialysis. Gazi Zibari, M.D., Hosein Shokouh-Amiri, MD Chapter 6. Peritoneoscopic Placement of Peritoneal Dialysis Catheters Rick Mischler M.D., Jeff Packer, D.O. Table of the Contents Chapter 1 9 Chapter 7. Fluoroscopic Placement of Peritoneal Dialysis Catheters Kenneth Abreo M.D., Bharat Sachdeva, M.D., Ivan Maya, M.D. Chapter 8. Peritoneal Catheter Removal and Complications of Peritoneal Dialysis Catheters Loay Salman M.D. and Arif Asif M.D. Chapter 9. CPT Coding of Peritoneal Dialysis Catheter Related Procedures Donald Schon M.D., Shouwen Wang, M.D. Chapter 1 - Sample Page Chapter 2 2
3 Chapter 2 - Sample Figures Chapter 3 Chapter 4 Chapter 4 - Sample Table Chapter 5 Chapter 5 - Sample Figures 3
4 Chapter 5 - Sample Figures Chapter 5 - Sample Figures Chapter 6 Chapter 6 - Sample Figure Chapter 7 Chapter 7 - Sample Page with Figure 4
5 Chapter 8 Chapter 8 - Sample Table Chapter 8 - Sample Page with Figure Chapter 9. Chapter 9. Sample Tables The 1 st Edition 5
6 PD as a CVC Avoidance Strategy Kenneth Abreo, M.D. Professor & Chief Division of Nephrology Financial Disclosure Discussion Points None The CVC Problem The Dark Side of CVCs Why is a PD catheter preferable to a CVC? Strategy s for CVC avoidance Barriers to PD selection PD in the early and late referred CKD patient AVF placement in the PD patient Discussion Points The CVC Problem The Dark Side of CVCs Why is a PD catheter preferable to a CVC? Strategy s for CVC avoidance Barriers to PD selection PD in the early and late referred CKD patient AVF placement in the PD patient The CVC Problem 82% of patients in the US initiated HD with a CVC in 2006 Hakim & Himmelfarb, KI 2 6
7 The CVC Problem 75% of patients followed by Nephrologists for > 6 months initiated HD with a CVC Hakim & Himmelfarb, KI 2 Discussion Points The CVC Problem The Dark Side of CVCs Why is a PD catheter preferable to a CVC? Strategy s for CVC avoidance Barriers to PD selection PD in the early and late referred CKD patient AVF placement in the PD patient The Dark Side of CVCs Inadequate HD with CVC when compared to AVF and AVG CVC induced central vein stenosis and thrombosis poses a threat to successful AVF and AVG placement Most important, a very high incidence of catheter-associated associated blood stream infections resulting in a high mortality % Vascular Access Infections 5 0 AVF AVG CATH <3MO CATH>6MO CRB ranges from episodes per 1000 catheter-days K/DOQI guideline RR 1 MORTALITY RR of Death by Access Prevalence CVC AVG AVF DM NO DM Discussion Points The CVC Problem The Dark Side of CVCs Why is a PD catheter preferable to a CVC? Strategy s for CVC avoidance Barriers to PD selection PD in the early and late referred CKD patient AVF placement in the PD patient Dhingra PK et al KI, 2001;60(4) 7
8 Why is a PD catheter preferable to a CVC? PD catheters have lower infection rate than CVC Superior early survival (debated) Better outcome after renal transplantation Lower risk of HBV and HCV infections Better QOL and autonomy Preservation of vascular real estate Ref: Ishani et al, KI 68:311, 2005; Foley et al, JASN 15:1038, 2004; Biesen et al, JASN 11:116, 2000; Rubin et al JAMA 291:697, 2004; Kutner et al, NDT 20:2159, 2005 Access Related Infection in the USRDS Wave 2 Study PC AVF PD HR 95%CI PC TC AVG AVF 1 Ref Ishani PD et 0.96 al, KI :311, Why is a PD catheter preferable to a CVC? PD catheters have lower infection rate than CVC, comparable to AVFs Superior early survival (debated) Better outcome after renal transplantation Lower risk of HBV and HCV infections Better QOL and autonomy Preservation of vascular real estate Discussion Points The CVC Problem The Dark Side of CVCs Why is a PD catheter preferable to a CVC? Strategy s for CVC avoidance Barriers to PD selection PD in the early and late referred CKD patient AVF placement in the PD patient Strategies for Avoiding CVC Role of Nephrologist: Early referral for AVF placement (egfr rule, 6 m before use) Patient related factors: Early education Role of Vascular Surgeon: Training in surgical techniques Prompt intervention by Interventionalist Role of Insurance Industry Peritoneal Dialysis as bridge therapy Discussion Points The CVC Problem The Dark Side of CVCs Why is a PD catheter preferable to a CVC? Strategy s for CVC avoidance Barriers to PD selection PD in the early and late referred CKD patient AVF placement in the PD patient 8
9 Barriers to PD Selection Survey of 1365 patients starting HD in Network 18 1/3 of patients were unaware of their kidney disease and saw a nephrologist <4 months before HD 1/2 of patients were presented with treatment options either after or <1 month before the first HD 2/3 of patients were not presented with PD as a treatment option Discussion Points The CVC Problem The Dark Side of CVCs Why is a PD catheter preferable to a CVC? Strategy s for CVC avoidance Barriers to PD selection PD in the early and late referred CKD patient AVF placement in the PD patient Mehrotra et al, KI 68:378, 200 Early Referral and Selection of PD as a Treatment Modality Early referral defined as first visit to a nephrologist 4 months before initiation of dialysis Early referral combined with a responsible, well- balanced presentation of therapeutic options is associated with increased selection of PD as the initial therapy Who is more likely to select PD over HD? Young age, white race, fewer co-morbid conditions Employed, married, living with someone, more autonomous or more accomplished educationally Seen earlier (>4 months) and more frequently (> 2 visits) by a Nephrologist Ref: Prichard, PDI 1996; USDS Wave 2, AJKD 1997; Obrador & Pereira, AJKD 1998; Schmidt et al, AJKD 1998; Diaz-Buxo, PDI 1998; Van Biesen et al, PDI 1999 Stack A, JASN 13:1279,200 Can PD be Initiated in the Late-Referred ESRD Patient (no vascular access or immature AVF)? 52 patients with ESRD started on 12-hour APD Coiled, double-cuffed Tenkhoff catheters inserted by open surgery under local anesthesia and without the use of prophylactic antibiotics Exceptionally good surgical support 7 days a week Standard prescription for acute APD was: 12h overnight, total volume 10L with maximum dwell volume 1.2L (BW<60 Kg) or 14L with maximum dwell volume 1.5L (BW>60Kg), tidal volume 50-75% Supine at night, free to walk during dry day Povlsen & Ivarson, NDT 200 Comparison of Acute vs Planned PD Acute Planned P 52(%) 52(%) Infectious complications 10 (19.2) 11 (21.2) NS Mechanical complications 15 (28.9) 4 (7.7) <0.01 Surgical replacement 10 (19.2) 2 (3.9) < PD technique survival at 3 mo. 39/52 (75) 45/52 (86.5) NS PD technique survival, censored for death & transplantation 39/45 (86.7) 45/50 (90) NS Povlsen & Ivarson, NDT 20 9
10 Discussion Points The CVC Problem The Dark Side of CVCs Why is a PD catheter preferable to a CVC? Strategy s for CVC avoidance Barriers to PD selection PD in the early and late referred CKD patient AVF placement in the PD patient PD Patients Can Benefit from a Back Up AVF Permanent transfer from PD to HD: Recurrent peritonitis, inadequate small solute clearance (uremia), UF failure (volume XS, HTN, CHF) and patient burn out Temporary transfer from PD to HD: Volume overload, hernia repair, intra-abdominal abdominal surgery AVF should be placed at the time of or soon after PD catheter placement to allow maturation Having an AVF will avoid the placement of a CVC Conclusions Yes, it is possible to place a PD catheter as a CVC avoidance strategy It involves education of the patient and in some instances the nephrologist In some instances the patient may choose to stay on PD permanently Patients on PD may benefit from having a back up AVF ULTRASOUND AND HEMODIALYSIS ACCESS Vandana Dua Niyyar, MD Assistant Professor of Medicine, Division of Nephrology, Emory University UTILITY OF ULTRASOUND AVF: Pre-operative arterial & venous AVF A Maturity Stenosis Angioplasty Thrombosis Clot Burden Steal syndrome AVG: Stenosis Angioplasty PseudoaneurysmP d Peri-graft infection Central Venous Catheters: Placement 10
11 ADVANTAGES DISADVANTAGES Non-invasive No need for contrast/radiation Widely available, Mobile Inexpensive Provides information on both morphology (vessel anatomy) and function (blood flow) of vascular Dependent on operator expertise Time consuming Limited it field of view provides focal imaging Difficult to visualize central/more proximal stenosis due to depth limitations TECHNICAL CONSIDERATIONS B-Mode: Sound wave travels through tissue and reflected back towards transducer Velocity of sound independent of tissue type can be converted to anatomic depth 2-dimensional image produced based on time interval and intensity of sound TECHNICAL CONSIDERATIONS Color Doppler Color superimposed on B-Mode image Degree of color saturation Flow velocity Hue Direction of flow BART: Blue Away, Red Towards TECHNICAL CONSIDERATIONS Spectral Doppler Waveform analysis Quantitative measurement of velocity (PSV, RI) Power Doppler Power of signal related to the number of RBC s (not velocity) Useful in slow flow/near occlusion SPECTRAL WAVEFORM RESPIRATORY PHASICITY Guidelines for noninvasive vascular laboratory testing. Journal of the American Society of Echocardiography Malovrh. The Role of USS in planning AVF for HD. Seminars in Dialysis
12 HIGH-RESISTANCE ARTERY LOW-RESISTANCE AVF Malovrh. The Role of USS in planning AVF for HD. Seminars in Dialysis Malovrh. The Role of USS in planning AVF for HD. Seminars in Dialysis CENTRAL VENOUS EVALUATION Frequent use of central catheters results in central vein stenosis Ultrasound unable to visualize the subclavian and brachiocephalic vein But may get indirect evidence of central venous abnormality using Slide Courtesy: Dr Work lt d CENTRAL VENOUS EVALUATION Patel et al Subclavian and internal jugular veins at Doppler US: abnormal cardiac pulsatility and respiratory phasicity as a predictor of complete central AVF MATURITY FOR USE THROMBOSED GRAFT AVF MATURITY FOR USE If fistula diameter was 0.4 cm or greater, the chance that it would be adequate for dialysis was 89% versus 44% if size was less. If fistula blood flow was 500 ml/min or greater, the chance that it would be adequate was 84% versus 43% if it was less. Combining the two variables, the chance that it would be adequate was 95% versus 33% if neither of the criteria were met. Experienced dialysis nurses had a 80% accuracy in predicting the ultimate utility of a fistula for dialysis. Robbin et al. Radiology 2002; 225:
13 STENOSIS Luminal diameter reduction > 50% Peak systolic flow velocity (PSV) > 400 cm/sec PSV ratio across stenosis >2.0 High resistance Doppler waveform Decrease in access flow volume Percent stenosis: (Original lumen residual lumen)/ Original lumen Sensitivity 76-87% cf. angiography Middleton et al. CD of HD access: comparison with angiography. Am J Radiol 1989; 152: Tordoir et al Duplex USS in assessment of AVF for HD: comparison with DSA J Vasc Surg AVF JUXTA- ANASTOMOTIC STENOSIS PSV 91 cm/s PSV 636 cm/s 12 HD Access USS. Lockhart & Robbin. Ultrasound Quarterly (3), AVF JUXTA-ANASTOMOTIC STENOSIS PS V 13 0 PSV 438 ACCESS FLOW VOLUME PTFE AVG Measure anywhere along the access Flow < 650 ml/min steadily increasing RR of thrombosis AVF Measure at feeding brachial artery/avf Flow < 500 ml/min access dysfunction Grogan et al. Freq of critical stenosis in primary AVF: Shd Duplex USS be std of care? J Vasc Su Weise et al. Color Doppler USS in Dialysis Access NDT (2004) 19: 195 ACCESS FLOW VOLUME Weise et al. Color Doppler USS in Dialysis Access NDT (2004) 19: 19 ANGIOPLASTY Duplex guided balloon angioplasty Small, uncontrolled studies Successful in both grafts 1 and fistulae 2 May be used intra-operatively for arterial stenosis May be used post-operatively operatively for immature/failing AVF 1. CD USS PTA of grafts. Bacchini et al. Journal of Vascular Access 2007; 8:81-2. Duplex-guided balloon angioplasty of AVF: A new office-based procedure. Asc Surg 2009; 50:
14 ANGIOPLASTY May be used intra-operatively for arterial stenosis 7 patients with arterial stenosis, diagnosed pre- operatively by USS Dimensions i of angioplasty balloon decided d pre- operatively by USS Wires, balloons and stents inserted through the arteriotomy; inflation 8-13 atm for 30 sec 5 AVF matured and were successfully used 2 AVF (stents) unsuccessful Intra-op USS guided angioplasty of arterial stenosis during u AVF creation. Napoli et al. Journal of Vascular Access 2007 ANGIOPLASTY 32 office-based procedures on 25 patients Non-maturing (27) and failing (5) AVF All 5 failing AVF salvaged 24/27 successfully used for dialysis within 3 months after last procedure Primary cumulative patency at 1, 3 and 6 months: 96%, 76% and 53% Duplex-guided balloon angioplasty of AVF: A new office-based procedure. Ascher et al. J Vasc S THROMBUS BURDEN COLOR DOPPLER - STEAL Weise et al. Color Doppler USS in Dialysis Access NDT (2004) 19: Weise et al. Color Doppler USS in Dialysis Access NDT (2004) 19: 195 COLOR DOPPLER - STEAL NORMAL GRAFT 7 HD Access USS. Lockhart & Robbin. Ultrasound Quarterly (3), HD Access USS. Lockhart & Robbin. Ultrasound Quarterly (3),
15 VECTRA GRAFT GRAFT STENOSIS CD USS of polyurethane vascular graft for HD. Wiese et al. NDT (2003) 18:139 Toya et al. Periodic duplex USS with elective PTA in AVG. Surg Today GRAFT STENOSIS OUTFLOW VEIN STENOSIS PSV PSV HD Access USS. Lockhart & Robbin. Ultrasound Quarterly (3), THROMBOSIS PERI-GRAFT INFECTION HD Access USS. Lockhart & Robbin. Ultrasound Quarterly (3), HD Access USS. Lockhart & Robbin. Ultrasound Quarterly (3),
16 GRAFT PSEUDOANEURYSM ULTRASOUND IN CATHETER PLACEMENTS Blind cannulations should not be routinely done No excuse technology is readily available Complication rate 5% Ultrasound guided cannulation is mandatory 6 HD Access USS. Lockhart & Robbin. Ultrasound Quarterly (3), ANATOMICAL VARIATIONS SUMMARY Non-invasive Widely available Avoids exposure to contrast/radiation Relatively inexpensive May be used across the spectrum for HD access pre-, intra- and post-operatively operatively An excellent tool in the interventionist s armamentarium Slide Courtesy: Dr Work 16
ASDIN 7th Annual Scientific Meeting DISCLOSURES TECHNICAL CONSIDERATIONS TECHNICAL CONSIDERATIONS UTILITY OF ULTRASOUND IN EVALUATING ACCESS
DISCLOSURES UTILITY OF ULTRASOUND IN EVALUATING ACCESS DYSFUNCTION None Vandana Dua Niyyar, MD Assistant Professor of Medicine, Division of Nephrology, Emory University UTILITY OF ULTRASOUND IN ACCESS
More informationASDIN 7th Annual Scientific Meeting
Strategies for Decreasing the Use of Hemodialysis Catheters ASDIN 7 th Annual Scientific Meeting Outline Late referral Primary failure Why Not PD? Summary Micah Chan MD MPH FACP Assistant Professor of
More informationIntroduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents
Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents Jesus Contreras, D.O. PGY-4 John Yasmer, D.O. Department of Radiology No Disclosures Objectives Introduce
More informationPostoperative AV Fistula Evaluation. Postoperative examination protocol. Postoperative AVF Protocol. Hemodialysis Access Surveillance
Hemodialysis Access Surveillance Postoperative AV Fistula Evaluation Failure of maturation Stenosis Perigraft mass/fluid collection Joseph L. Mills, Sr., M.D. Professor of Surgery Chief, Division of Vascular
More informationHD Scanning: Velocities and Volume Flow
HD Scanning: Velocities and Volume Flow Non-Invasive Lab Symposium West Orange, NJ April 27, 2018 Volume Flow Cindy Sturt, MD, FACS, RVT 500,000 Americans on dialysis 20-25% annual mortality 65% 5 year
More informationKDOQI Guidelines. Overview. Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium
DISCLOSURES: NONE Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium KDOQI Guidelines AV fistulas have better outcomes than grafts or catheters
More informationPreservation of Veins and Timing for Vascular Access
Preservation of Veins and Timing for Vascular Access Vassilis Liakopoulos, MD, PhD Department of Nephrology School of Medicine University of Thessaly Greece Hemodialysis VA A sound long-term dialysis access
More informationSid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face
Sid Bhende MD Sentara Vascular Specialists April 28 th 2018 Dialysis Access Review: Understanding the Access Options our Patients Face Disclosures Dialysis Background Why is it important? Outline National
More informationMedical Director/Surgeon as Partners WebEx February 11, 2010
Medical Director/Surgeon as Partners WebEx February 11, 2010 Over 400,000 patients are treated yearly for ESRD in the USA; 60% of these patients receive some form of hemodialysis Despite major advances
More informationTechnical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access
Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access Louise Moist Associate Professor Lead Vascular Access Ontario Renal Network Schulich School of Medicine University
More informationWhat s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute
What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute Disclosures No relevant disclosures Employee Advanced Access Care Dialysis Work 5 operating surgeons 3
More informationGoals. Access flow and renal artery stenosis evaluation by Doppler ultrasound. Reimbursement. WHY use of Doppler Ultrasound
Access flow and renal artery stenosis evaluation by Doppler ultrasound Adina Voiculescu, MD Interventional Nephrology Brigham and Women s Hospital Boston Instructor at Harvard Medical School Understand
More informationFistula Maturation Failure. Successful AVF. ASDIN 2014 Scientific Meeting
Fistula First "Unassisted" evaluation of access dysfunction (eyes, ears, and fingers) Tushar Vachharajani, MD Chief, Nephrology Section W. G. (Bill) Hefner VAMC Salisbury, NC Quality improvement projects
More informationSelection of Permanent Hemodialysis Vascular Access
Selection of Permanent Hemodialysis Vascular Access TABLE OF CONTENTS 1.0 Scope...1 2.0 Recommendations & Rationale... 2 3.0 References... 3 4.0 Sponsors... 9 5.0 Effective Date... 10 Appendix 1: Key Elements
More informationRenal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc non-mips Measure Specifications
Renal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc. 2018 non-mips Measure Specifications Last updated January 2, 2018 RPAQIR1: Angiotensin Converting Enzyme (ACE)
More informationInterventions for AV-Shunt stenosis: What works best PTA, Stent or DCB?
Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB? Martin Forlee Vascular Surgeon Cape Town Disclosure Speaker name: Martin Forlee I have the following potential conflicts of interest
More informationMIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai
MIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai i Postgraduate Training Program at Chubu Hospital, Okinawa,
More informationGerald Beathard Annual State of the Art Lecture Innovations in Vascular Access - Have We Moved Forward?
Gerald Beathard Annual State of the Art Lecture Innovations in Vascular Access - Have We Moved Forward? Maurizio Gallieni Nephrology and Dialysis Unit Ospedale S. Carlo Borromeo, ASST Santi Paolo e Carlo,
More informationJimmy Wei Hwa Tan, Surg, MD
Jimmy Wei Hwa Tan, Surg, MD Director, Department of Surgery Chief, Department of Cardiovascular Surgery Tainan An-Nan Municipal Hospital, China Medical University, Taiwan Disclosure I have the following
More informationCATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care
CATHETER REDUCTION Angelo N. Makris, M.D. Medical Director Chicago Access Care Objectives Discuss tools/techniques proven to improve AVF rates & decrease catheter rates Implement a change process in your
More informationWhy Can't I Cannulate This Fistula? Fistula Immaturity: The Simple But Critical Steps for a Functioning (Mature) AVF
Why Can t I Cannulate This Access? Steven J. Bander M.D. Adjunct Professor of Nephrology St. Louis University Director, Vascular Access Center, St. Luke s Hospital Saint Louis, MO Why Can't I Cannulate
More informationTale of Neglected Aneurysm
Disclosures Tale of Neglected Aneurysm Consultant to FFCL Tushar Vachharajani, MD, FASN Chief, Nephrology Section Salisbury VAMC, NC Objectives How do you define Aneurysm? When and How do you treat? Defining
More informationCannulation Techniques Webinar
Cannulation Techniques Webinar March 28, 2012 ESRD Network of Texas Lynda K. Ball, MSN, RN, CNN Objectives Discuss assessment skills inspection, palpation, and auscultation of an AV fistula to determine
More informationIN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators
IN.PACT AV Access IDE Study Full Baseline Data Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators Disclosures Speaker name: Robert Lookstein, MD... I have the following
More informationDialysis Initiation and Optimal Vascular Access: Outcomes and Mortality
Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Shannon H. Norris, BSN, RN June 6, 2018 Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality DISCUSSION: End Stage
More informationAV ACESS COMPLICATIONS. Ass. Prof. Dr. Habas
AV ACESS COMPLICATIONS Ass. Prof. Dr. Habas COMPLICATION AVF IS CONSIDERED A MINOR PROCEDURE INCIDENCE OF COMPLICATION- 20-27% MANY A COMPLICATION LEADS TO FAILURE OF FISTULA LOSS OF SITE AND VEIN FOR
More informationCase #1. Case #1- Possible codes. Unraveling the -59 modifier. Principles of Interventional. CASE 1: Simple angioplasty
Unraveling the -59 modifier Principles of Interventional Coding Donald Schon, MD, FACP Debra Lawson, CPC, PCS Distinct or independent from other services performed on the same day Normally not reported
More informationCardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access
Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access Theodore F. Saad, MD Nephrology Associates, PA Christiana Care Health System Newark, Delaware Cardiovascular Implantable
More information2006 NKF-DOQI Guidelines Preferred Vascular Access Order 1. Radiocephalic (wrist) fistula 2. Brachiocephalic (elbow) fistula 3. Basilic vein transposi
Stage 5 Chronic Kidney Disease Assessing the Results of AV Access: Realistic Outcomes in 2009 Sean P. Roddy, MD Albany, NY Defined as a GFR
More informationNarender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York
Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,
More informationDr. Murty Mantha MD FRACP Cairns Base Hospital Cairns. DNT 2011 Hunter Valley
Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns DNT 2011 Hunter Valley Approximately 45% of AVF are functional without intervention after creation The procedure rate is 1.45-3.3 procedures/avf
More informationASDIN 8th Annual Scientific Meeting
Fistula First Breakthrough Initiative Fistula First Breakthrough Initiative Marianne Neumann, RN, CNN FFBI Clinical Lead New Orleans, LA February 26, 2012 Initiated in 2003 by CMS, Goals Include: to ensure
More informationUPDATE IN VASCULAR ACCESS Mercedeh Kiaii MD FRCPC Rick Luscombe RN BSN CNeph(C) Elizabeth Lee MD FRCPC
UPDATE IN VASCULAR ACCESS Mercedeh Kiaii MD FRCPC Rick Luscombe RN BSN CNeph(C) Elizabeth Lee MD FRCPC Background Endovascular AVF Outline Data from FLEX and NEAT study SPH data Clinical experience Cannulation
More informationJVA ISSN Hemodialysis vascular access management in the Netherlands. Introduction ORIGINAL ARTICLE
JVA ISSN 1129-7298 J Vasc Access 2015; 16 (Suppl 9): S11-S15 DOI: 10.5301/jva.5000366 ORIGINAL ARTICLE Hemodialysis vascular access management in the Netherlands Jan H.M. Tordoir 1, Magda M. van Loon 1,
More informationCase Endovascular management of non maturing dyalisis vascular access
Case 10238 Endovascular management of non maturing dyalisis vascular access Guedes Pinto 1, Erique; Madeira 2, Célia; Sousa 3, Marta; Penha 1, Diana; Rosa 1, Luís; Germano 1, Ana; Baptista 1, Manuela 1
More informationJuxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)?
Juxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)? Richard Shoenfeld MD, FSIR, FAHA The Access Center at West Orange West Orange, New Jersey USA SEDAV 2015 Madrid November
More informationRegardless of whether you are a vascular surgeon,
C A S E R E P O R T The Versatility of the GORE VIABAHN Endoprosthesis Several case reports highlighting its unique design and why it is a valuable tool for the interventionist. BY PETER WAYNE, MD Regardless
More informationDifference in practical dialysis therapy between East Asia and US/EU
Difference in practical dialysis therapy between East Asia and US/EU Jer-Ming Chang. M.D., Ph.D. 1 Professor, Attending physician, Kaohsiung Medical University Hospital; 2 Secretary General, Taiwan Society
More informationQuality ID #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care
Quality ID #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE:
More informationASDIN 9th Annual Scientific Meeting
Can Interventional Programs (IN) Help Popularize Home Dialysis Therapies? Gerald Beathard State of the Art Lecture ASDIN Washington, DC February 16, 2013 Stephen R. Ash, MD, FACP Indiana University Health
More informationDisclaimer. PD Catheter Placement in Urgent and Emergent Peritoneal Dialysis. Catheter design and outcomes CATHETER DESIGN AND OUTCOME
ASDIN 2014 Scientific Meeting Disclaimer PD Catheter Placement in Urgent and Emergent Peritoneal Dialysis Bharat Sachdeva M.D. Associate Professor of Medicine/Nephrology Interventional Nephrology Division
More informationMeasure #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care
Measure #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY This is
More informationDeveloping a Quality Assurance Performance Improvement (QAPI) Program at Your Dialysis Center Rudolph P. Valentini, M.D. Associate Professor of Pediatrics Director of Dialysis Services Vice Chief of Staff
More informationDISCLOSURE TEST YOUR WAVEFORM IQ. Partial volume artifact. 86 yo female with right arm swelling, picc line. AVF on left? Dx?
Deborah Rubens University of Rochester Rochester, NY DISCLOSURE Neither I nor my immediate family have a financial relationship with a commercial organization that may have a direct or indirect interest
More informationDuplex Ultrasound of the Renal Arteries. Duplex Ultrasound. In the Beginning
Duplex Ultrasound of the Renal Arteries DIMENSIONS IN HEART AND VASCULAR CARE 2013 PENN STATE HEART AND VASCULAR INSTITUTE ROBERT G. ATNIP MD PROFESSOR OF SURGERY AND RADIOLOGY Duplex Ultrasound Developed
More informationVascular Access Options for Apheresis Medicine
Vascular Access Options for Apheresis Medicine Josh King, MD Divisions of Nephrology and Medical Toxicology University of Virginia September 21, 2018 Disclosure I have no personal or professional financial
More informationProspective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access
Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access Disclosure Speaker name:... I have the following potential conflicts
More informationDisclosures. History. Case. Using the peritoneal cavity for dialysis. Background 2/4/2015 ASDIN PD in the Acute Setting- Myth or Reality?
PD in the Acute Setting- Myth or Reality? ASDIN Scientific Meeting February 15, 2015 Disclosures Investigator: BARD, Otsuka, Shire, Gilead Grants: Amgen Consultant: Covidien, Deltanoid No disclosures for
More informationDistal Hypoperfusion Ischemic Syndrome (DHIS)
Pathophysiology Traditional View ( Steal Syndrome ) Distal Hypoperfusion Ischemic Syndrome (DHIS) Steven Wu, MD Director of Interventional Nephrology Massachusetts General Hospital Harvard Medical School
More informationA Case for Mandatory Routine Graft Surveillance of lower extremity bypass grafts. Avishai Meyer UCHSC resident, Surgery May 8, 2006
A Case for Mandatory Routine Graft Surveillance of lower extremity bypass grafts Avishai Meyer UCHSC resident, Surgery May 8, 2006 Outline: Definition Background of terms and studies U/S surveillance What
More informationIncident Hemodialysis
The Acute Kidney Injury Group Modifying the Highest Mortality Rate in the Major AKI Adverse Outcome Other than Death: Loss ESRD & Incident Hemodialysis The EVA QI Program Integrated Inpatient Early Vascular
More informationVascular Access for Haemodialysis. Mike Stephens
Vascular Access for Haemodialysis Mike Stephens Overview Learning Objectives History and development of vascular access Standards in vascular access surgery Types of vascular access Complications Objectives
More informationMeasure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety
Measure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY This is a
More informationHemodialysis Fistula Maturation Consortium
Hemodialysis Fistula Maturation Consortium Rationale for Fistula Maturation Study Dialysis Access Consortium AVF study 60% of new AVFs were unusable for dialysis at 4-5 months post surgery No predictors
More informationAVF Prevalence. Local elastase to aid fistula maturation. I have nothing to disclose
Local elastase to aid fistula maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2013 UCSF Vascular Symposium I have nothing to disclose AVF Prevalence 60.6% (April 2012) Fistula First Initiative
More informationInnovation in Technology II: Changed and Improved Design. PD Catheters- designs. Bharat Sachdeva MD LSU Shreveport
Innovation in Technology II: Changed and Improved Design PD Catheters- designs Bharat Sachdeva MD LSU Shreveport What s at risk? Why Is Material/Design Important? Reduce risk for transfer to HD Displacement
More informationFirst experience with DCB for treatment of dialysis access stenosis The Greek experience
First experience with DCB for treatment of dialysis access stenosis The Greek experience D Karnabatidis Department of Interventional Radiology Patras University Hospital Patras, Greece Background Vessel
More informationCOVERA Vascular Covered Stents in the Management of Dysfunctional AV Access
COVERA Vascular Covered Stents in the Management of Dysfunctional AV Access Bart L. Dolmatch, M.D., FSIR Palo Alto Medical Foundation Mountain View, CA USA This presentation is being made on behalf of
More informationUC SF. End Stage Renal Disease. National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) BUT-- No Cephalic Vein What s Next
No Cephalic Vein What s Next End Stage Renal Disease Charles Eichler MD Clinical Professor of Surgery Division of Vascular Surgery UCSF April 5, 2014 Population of patients with ESRD growing rapidly -
More informationBare Metal Stents vs Stent Grafts
Bare Metal Stents vs Stent Grafts ASDIN 12th Annual Scientific Meeting Phoenix, AZ, February 20, 2016 Dirk Hentschel, MD Director, Interventional Nephrology Brigham and Women s Hospital Disclosure Consultant:
More informationIntroduction. Introduction 2/18/2015 ASDIN Vascular Access complications: High associated morbi-mortality. Worsened quality of life
Introduction Vascular Access complications: Ultrasound Evaluation of the Mature AVF and Process Improvement High associated morbi-mortality Worsened quality of life Up to 25 % hospitalized Jose Ibeas M.D.,
More informationEnd-Stage Renal Disease. Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology
End-Stage Renal Disease Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology ESRD : Life with renal replacement therapy CASE: 18 month old male with HUS develops ESRD PD complicated
More information*PTA Failure: Recoil >30% stenosis or more than 2 PTA s within 3 mo. Bart Dolmatch, MD
The views presented reflect those of the author/presenter and do not necessarily reflect those of ASDIN nor serve as an endorsement of safety, efficacy or applicability of said procedure. the Endovascular
More informationSt George Hospital Renal Department Internal Policy
COMPLICATIONS OF VASCULAR ACCESS FOR HAEMODIALYSIS. SUMMARY: Any type of complication for either a centrally placed venous catheter or arterio-venous fistula/graft can place the patient at risk of sub-optimal
More informationChapter Five Clinical indicators & preventive health
Chapter Five Clinical indicators & preventive health The painter who draws merely by practice and by eye, without any reason, is like a mirror which copies every thing placed in front of it without being
More informationThe Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice
The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice Dr Kate Steiner Consultant Interventional Radiologist East and North Hertfordshire NHS Trust Disclosure Speaker name: Dr
More informationASDIN 9th Annual Scientific Meeting
Stent Graft Placement is Best for Cephalic Arch and Central Vein Stenosis Dheeraj K. Rajan MD, FRCPC, FSIR Head - Division of Vascular and Interventional Radiology University of Toronto University Health
More informationDoppler ultrasound role in the evolution and evaluation of the complications of vascular hemodyalisis access.
Doppler ultrasound role in the evolution and evaluation of the complications of vascular hemodyalisis access. Poster No.: C-1675 Congress: ECR 2015 Type: Educational Exhibit Authors: M. E. Banegas Illescas,
More informationDecreased Incidence of Clotted AV Access in Hemodialysis Patients after the Implementation of Follow up Program
Global Journal of Health Science; Vol. 8, No. 10; 2016 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Decreased Incidence of Clotted AV Access in Hemodialysis Patients
More informationLutonix in AV fistula and Early look AV IDE trial data
Lutonix in AV fistula and Early look AV IDE trial data Jackie P Ho Dept of Cardiac, Thoracic & Vascular Surgery National University of Singapore NUHS, Singapore Lutonix in AV fistula and final AV IDE trial
More informationSupera for the Juxta-anastomotic AVF Stenosis
Supera for the Juxta-anastomotic AVF Stenosis Dr Shannon D. Thomas Vascular Access Surgeon Conjoint Senior Lecturer University of New South Wales Sydney, Australia Disclosure Speaker name: Dr S. D. Thomas...
More informationWhat effects will proximal or distal disease have on an waveform?
Spectral Doppler Interpretation Director Director of of Ultrasound Ultrasound Education Education & & Quality Quality Assurance Assurance Baylor Baylor College College of of Medicine Medicine Division
More informationLutonix AV Clinical Trial
Long Term Effects of LUTONIX 035 DCB Catheter Interim 24 Month Results Scott O. Trerotola, MD, for the Lutonix AV Investigators Stanley Baum Professor of Radiology Professor of Radiology in Surgery Associate
More informationVascular Access Care Plans: How Can a Care Plan Really Improve Care and Make Everyone s Job Easier?
Vascular Access Care Plans: How Can a Care Plan Really Improve Care and Make Everyone s Job Easier? Plan the Work Work the Plan What is a plan? A method for achieving an end An orderly arrangement of parts
More informationThe HeRO Graft. Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center
The HeRO Graft Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center Faculty Disclosure I disclose the following financial relationships: CryoLife/Hemosphere, Inc. & W.L. Gore and
More informationIl paziente anziano, evidenza e survey nazionale
Università La Sapienza Scuola di Specializzazione in Nefrologia Prof P. Menè Meeting di Nefrololgia Interventistica L Accesso Vascolare Impossibile Roma 23 Marzo 2016 Il paziente anziano, evidenza e survey
More informationLUTONIX AV Clinical Trial
LUTONIX AV Clinical Trial A Prospective, Global, Multicenter, Randomized, Controlled Study Comparing LUTONIX 035 AV Drug Coated Balloon PTA Catheter vs. Standard Balloon PTA Catheter for the Treatment
More informationNKF K/DOQI GUIDELINES
NKF K/DOQI GUIDELINES Executive Summaries Anemia Hemodialysis Peritoneal Dialysis Vascular Access Nutrition CKD 2002 Dyslipidemias Bone Metabolism Hypertension and Antihypertensive Agents Cardiovascular
More informationOutcomes Of Combined Rheolytic And Rotational Mechanical Thrombectomy For Total Access Circuit Thrombosis In Hemodialysis Patients
Outcomes Of Combined Rheolytic And Rotational Mechanical Thrombectomy For Total Access Circuit Thrombosis In Hemodialysis Patients Nicholas Petruzzi, MD Raphael Cohen, MD Mark Mantell, MD Timothy W. Clark,
More informationCoding of Procedures in Interventional Nephrology Produced in collaboration with:
Coding of Procedures in Interventional Nephrology 2013 Produced in collaboration with: Introduction Proper coding of interventional procedures is a difficult and daunting, but essential task. Each procedure
More informationAccess Preservation: Recurrent Central Venous Stenosis, Pacemaker Wires and other Nightmares. Who am I? Disclosures
Access Preservation: Recurrent Central Venous Stenosis, Pacemaker Wires and other Nightmares Jason Burgess, MD RVT Surgical Specialists of Charlotte CMC-Mercy Charlotte, NC Disclosures Gore Vascular- Consultant
More informationManagement of In-stent Restenosis after Lower Extremity Endovascular Procedures
Management of In-stent Restenosis after Lower Extremity Endovascular Procedures Piotr Sobieszczyk, MD Associate Director, Cardiac Catheterization Laboratory Cardiovascular Division and Vascular Medicine
More informationmorbidity & mortality
morbidity & mortality esrd introduction of ESRD treatment. We examine these concerns throughout the ADR, particularly in Chapter One. This year we focus on infectious complications, especially those related
More informationSurgical Options in Thrombectomy for Non-Surgeons
Surgical Options in Thrombectomy for Non-Surgeons Shouwen Wang, MD, PhD, FASDIN AKDHC Ambulatory Surgery Center Arizona Kidney Disease and Hypertension Center Phoenix, Arizona Disclosure No relevant financial
More informationDoppler Ultrasound: is it a third generation AVF surveillance method?
Doppler Ultrasound: is it a third generation AVF surveillance method? Jose Ibeas. Servei de Nefrologia Parc Tauli Sabadell, Hospital Universitari Barcelona Disclosures I have the following potential conflicts
More informationReview Article Duplex Ultrasound Evaluation of Hemodialysis Access: A Detailed Protocol
International Nephrology Volume 2012, Article ID 508956, 7 pages doi:10.1155/2012/508956 Review Article Duplex Ultrasound Evaluation of Hemodialysis Access: A Detailed Protocol Victoria Teodorescu, 1,
More informationVascular Surgery and Transplant Unit University of Catania. Pierfrancesco Veroux
Vascular Surgery and Transplant Unit University of Catania Pierfrancesco Veroux Bologna-Palazzo dei Congressi, 23 Ottobre 2017 Disclosure Speaker name: Prof. Pierfrancesco Veroux I have the following potential
More informationPercutaneous and Surgical Treatments
AVG Pseudoaneurysms Percutaneous and Surgical Treatments Marius Florescu M.D. Feb. 2015 ASDIN DEFINITION AVG Pseudoaneurysm Formation Incidence AVG Pseudoaneurysm incidence rate ranges between 2% and 10%
More informationTraining for Fluoroscopic Peritoneal Dialysis Catheter Placement. Rajeev Narayan MD San Antonio Kidney Disease Center San Antonio, TX
Training for Fluoroscopic Peritoneal Dialysis Catheter Placement Rajeev Narayan MD San Antonio Kidney Disease Center San Antonio, TX Disclosures No financial conflicts of interest to disclose. My comments
More informationPitfalls in pushing fistulas ----
Pitfalls in pushing fistulas ---- An argument for more grafts Marc Webb, MD, FACS Michigan Vascular Access, PC March 27 th, 2009 Vascular Access for Hemodialysis ------- Basic facts - the need for Access
More informationPercutaneous transluminal angioplasty in the treatment of stenosis of hemodialysis arteriovenous fistulae: our experience
Percutaneous transluminal angioplasty in the treatment of stenosis of hemodialysis arteriovenous fistulae: our experience Poster No.: C-3355 Congress: ECR 2010 Type: Scientific Exhibit Topic: Interventional
More informationDepartment of Vascular Surgery, Maastricht University, Maastricht - The Netherlands 2
The Journal of Vascular Access 2007; 8: 281-286 ORIGINAL ARTICLE Accessory veins and radial-cephalic arteriovenous fistula non-maturation: a prospective analysis using contrast-enhanced magnetic resonance
More informationInterventional Treatment for Complete Occlusion of Arteriovenous Shunt: Our Experience in 39 cases
Chin J Radiol 2003; 28: 137-142 137 Interventional Treatment for Complete Occlusion of Arteriovenous Shunt: Our Experience in 39 cases SHE-MENG CHENG SUK-PING NG FEI-SHIH YANG SHIN-LIN SHIH Department
More informationPre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease
Pre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease Michael R. Jaff, D.O., F.A.C.P., F.A.C.C. Assistant Professor of Medicine Harvard Medical School Director, Vascular Medicine
More informationUS of Renovascular Hypertension. Jonathan R. Dillman, MD, MSc Associate Professor Director, Thoracoabdominal Imaging
US of Renovascular Hypertension Jonathan R. Dillman, MD, MSc Associate Professor Director, Thoracoabdominal Imaging Disclosures Nothing Relevant Unrelated grant funding Siemens US Toshiba US Objectives
More informationWhat effects will proximal or distal disease have on a waveform?
Spectral Doppler Interpretation Director of Ultrasound Education & Quality Assurance Baylor College of Medicine Division of Maternal-Fetal Medicine Maternal Fetal Center Imaging Manager Texas Children
More informationFistula First? Vascular Symposium 4/28/18
Fistula First? Vascular Symposium 4/28/18 Disclosure I have no financial interest to disclose connected to any of the information presented in this discussion Objectives Scope of Problem Benefits of PD
More informationDisclosure. Speaker name: Prof. Hesham Aly Sharaf El-Din. I do not have any potential conflict of interest
Disclosure Speaker name: Prof. Hesham Aly Sharaf El-Din I do not have any potential conflict of interest Introduction 5% of patients with upper limb AVF develop ipsilateral hand ischemia, recently termed
More information